Globant and PharmaMar Collaborate to Accelerate Cancer Drug Discovery
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 19 2026
0mins
Should l Buy GLOB?
Globant and PharmaMar announced a new collaboration designed to speed up cancer drug discovery through artificial intelligence. Through Globant Enterprise AI, the two organizations have created a multi-agent AI system that delivers more than 90% accuracy in complex data retrieval and reduces time to insights up to 15-fold, helping scientists select high-potential drug candidates for clinical development in a fraction of the time previously required.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GLOB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GLOB
Wall Street analysts forecast GLOB stock price to rise
13 Analyst Rating
5 Buy
8 Hold
0 Sell
Moderate Buy
Current: 45.680
Low
61.00
Averages
76.36
High
100.00
Current: 45.680
Low
61.00
Averages
76.36
High
100.00
About GLOB
Globant S.A. is a digitally native technology services company. The Company’s principal operating subsidiary is based in Buenos Aires, Argentina. During the year ended December 31, 2015, 83.7% of its revenues were generated by clients in North America, 11.0% in Latin America and Asia, and 5.3% in Europe. It builds digital journeys, which consists of different software products, including mobile apps, Web apps, sensors and other software and hardware appliances that work orchestrated by a backend that uses big data and fast data to create a understanding of each consumer and how to act upon each scenario. The Company delivers digital journeys with a comprehensive approach that includes Stay Relevant, which helps its customers stay fit for the future of their industries; Discover, which think and conceive specific digital journeys for each customer; Build, which creates each digital journey leveraging the work of its Studios, its services over platforms and its agile pods methodologies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Globant to Hold Annual Shareholders Meeting on April 28, 2026
- Shareholder Meeting Announcement: Globant S.A. is set to hold its Annual General Meeting on April 28, 2026, at its headquarters in Luxembourg, where future development and strategic directions will be discussed, ensuring shareholder engagement and transparency in governance.
- Notice of Meeting Released: The company has published the convening notice on its website, including the agenda, proxy card, and relevant materials, aimed at enhancing shareholder participation and ensuring comprehensive information transparency.
- Company Overview: Globant focuses on digital and AI services, employing over 28,700 people across more than 30 countries, serving renowned companies like Google and Electronic Arts, which underscores its leadership position in the industry.
- Industry Recognition: Globant has been named a Worldwide Leader in CX Improvement by the IDC MarketScape report and featured as a business case study at Harvard, MIT, and Stanford, further solidifying its influence in the digital transformation space.
See More
Globant to Hold Annual Shareholders Meeting on April 28, 2026
- Shareholder Meeting Details: Globant S.A. will hold its Annual General Meeting on April 28, 2026, at its headquarters in Luxembourg, with the convening notice and agenda available on the company's website, ensuring shareholders have timely access to relevant information.
- Company Overview: As a digitally native technology services company, Globant employs over 28,700 people across more than 30 countries, serving renowned clients like Google and Electronic Arts, showcasing its extensive global reach and operational scale.
- Industry Recognition: The company has been named a Worldwide Leader in CX Improvement by the IDC MarketScape report and featured as a business case study at Harvard, MIT, and Stanford, highlighting its influence and innovative capabilities within the industry.
- Technological Innovation and Services: Through digital reinvention and subscription-based AI Pods, along with its Enterprise AI platform, Globant aims to transform client challenges into measurable business results, emphasizing its strategic importance in driving enterprise transformation.
See More
Globant to Hold Annual Shareholders Meeting on April 28, 2026
- Shareholder Meeting Details: Globant S.A. is set to hold its Annual General Meeting on April 28, 2026, at its registered office in Luxembourg, aimed at gathering shareholders to discuss the company's strategic direction.
- Meeting Materials Available: The company has made the convening notice, agenda, proxy card, and relevant materials available on its website, ensuring shareholders are well-informed and can participate in decision-making.
- Company Overview: With over 28,700 employees across more than 30 countries, Globant focuses on helping organizations transform through digital and AI-driven solutions, serving clients like Google, Electronic Arts, and Santander.
- Industry Recognition: Globant was named a Worldwide Leader in CX Improvement by the IDC MarketScape report and featured as a business case study at Harvard, MIT, and Stanford, highlighting its influence and innovation in the industry.
See More
Globant and PharmaMar Collaborate to Accelerate Cancer Drug Discovery
- AI System Enhances R&D Efficiency: The multi-agent AI system developed through the collaboration between Globant and PharmaMar achieves over 90% accuracy in complex data retrieval, reducing the time to select cancer drug candidates to one-fifteenth of the previous duration, significantly enhancing R&D efficiency.
- Massive Data Analysis Capability: The platform can analyze vast amounts of scientific, regulatory, and clinical data, assisting PharmaMar in making faster decisions within its R&D ecosystem and enabling continuous self-improvement workflows.
- Prioritization and Literature Review: The system reviews over 4,500 research documents to prioritize the 10 most promising treatment-indication combinations out of 8,000 possibilities, completing what would have taken months of work in a fraction of the time.
- Promotion of Digital Innovation Culture: This collaboration not only accelerates drug discovery speed and efficiency but also strengthens PharmaMar's ability to reuse institutional knowledge, fostering a culture of digital innovation within its teams.
See More
Globant and PharmaMar Collaborate to Accelerate Cancer Drug Discovery
- Multi-Agent AI System: The collaboration between Globant and PharmaMar has launched a multi-agent AI framework that achieves over 90% accuracy in complex data retrieval and reduces insight time by up to 15-fold, significantly accelerating the selection of cancer drug candidates.
- Efficient Data Processing: This system analyzes over 4,500 research documents to prioritize the 10 most viable treatment combinations out of 8,000 possibilities, a task that would have taken months for human researchers, now completed in seconds, greatly enhancing R&D efficiency.
- Innovation Culture Promotion: The partnership not only strengthens PharmaMar's ability to reuse institutional knowledge but also fosters a culture of digital innovation across teams, with plans to extend capabilities to hypothesis generation, real-time compliance checks, and automated scientific reporting content creation.
- Precision Drug Discovery: By integrating Globant's AI technologies, PharmaMar can process thousands of documents in seconds, simulate scenarios, and focus research efforts on areas with the highest potential, thereby offering greater hope for patient treatments.
See More
Globant Files 2025 Annual Report with SEC
- Annual Report Submission: Globant S.A. filed its 2025 Annual Report with the SEC on February 27, 2026, demonstrating the company's commitment to transparency and regulatory compliance.
- Financial Information Access: Shareholders can access the 2025 Annual Report via the company's or SEC's website and request free copies of the complete audited financial statements, reflecting the company's dedication to shareholder service.
- Global Business Presence: With over 28,700 employees across more than 30 countries, Globant serves prominent companies like Google, Electronic Arts, and Santander, showcasing its extensive influence in the digital technology services sector.
- Industry Recognition: The company was named a Worldwide Leader in CX Improvement by the IDC MarketScape report and featured as a business case study at Harvard, MIT, and Stanford, further solidifying its industry position.
See More
Globant to Hold Annual Shareholders Meeting on April 28, 2026
- Shareholder Meeting Announcement: Globant S.A. is set to hold its Annual General Meeting on April 28, 2026, at its headquarters in Luxembourg, where future development and strategic directions will be discussed, ensuring shareholder engagement and transparency in governance.
- Notice of Meeting Released: The company has published the convening notice on its website, including the agenda, proxy card, and relevant materials, aimed at enhancing shareholder participation and ensuring comprehensive information transparency.
- Company Overview: Globant focuses on digital and AI services, employing over 28,700 people across more than 30 countries, serving renowned companies like Google and Electronic Arts, which underscores its leadership position in the industry.
- Industry Recognition: Globant has been named a Worldwide Leader in CX Improvement by the IDC MarketScape report and featured as a business case study at Harvard, MIT, and Stanford, further solidifying its influence in the digital transformation space.
See More
Globant to Hold Annual Shareholders Meeting on April 28, 2026
- Shareholder Meeting Details: Globant S.A. will hold its Annual General Meeting on April 28, 2026, at its headquarters in Luxembourg, with the convening notice and agenda available on the company's website, ensuring shareholders have timely access to relevant information.
- Company Overview: As a digitally native technology services company, Globant employs over 28,700 people across more than 30 countries, serving renowned clients like Google and Electronic Arts, showcasing its extensive global reach and operational scale.
- Industry Recognition: The company has been named a Worldwide Leader in CX Improvement by the IDC MarketScape report and featured as a business case study at Harvard, MIT, and Stanford, highlighting its influence and innovative capabilities within the industry.
- Technological Innovation and Services: Through digital reinvention and subscription-based AI Pods, along with its Enterprise AI platform, Globant aims to transform client challenges into measurable business results, emphasizing its strategic importance in driving enterprise transformation.
See More
Globant to Hold Annual Shareholders Meeting on April 28, 2026
- Shareholder Meeting Details: Globant S.A. is set to hold its Annual General Meeting on April 28, 2026, at its registered office in Luxembourg, aimed at gathering shareholders to discuss the company's strategic direction.
- Meeting Materials Available: The company has made the convening notice, agenda, proxy card, and relevant materials available on its website, ensuring shareholders are well-informed and can participate in decision-making.
- Company Overview: With over 28,700 employees across more than 30 countries, Globant focuses on helping organizations transform through digital and AI-driven solutions, serving clients like Google, Electronic Arts, and Santander.
- Industry Recognition: Globant was named a Worldwide Leader in CX Improvement by the IDC MarketScape report and featured as a business case study at Harvard, MIT, and Stanford, highlighting its influence and innovation in the industry.
See More
Globant and PharmaMar Collaborate to Accelerate Cancer Drug Discovery
- AI System Enhances R&D Efficiency: The multi-agent AI system developed through the collaboration between Globant and PharmaMar achieves over 90% accuracy in complex data retrieval, reducing the time to select cancer drug candidates to one-fifteenth of the previous duration, significantly enhancing R&D efficiency.
- Massive Data Analysis Capability: The platform can analyze vast amounts of scientific, regulatory, and clinical data, assisting PharmaMar in making faster decisions within its R&D ecosystem and enabling continuous self-improvement workflows.
- Prioritization and Literature Review: The system reviews over 4,500 research documents to prioritize the 10 most promising treatment-indication combinations out of 8,000 possibilities, completing what would have taken months of work in a fraction of the time.
- Promotion of Digital Innovation Culture: This collaboration not only accelerates drug discovery speed and efficiency but also strengthens PharmaMar's ability to reuse institutional knowledge, fostering a culture of digital innovation within its teams.
See More
Globant and PharmaMar Collaborate to Accelerate Cancer Drug Discovery
- Multi-Agent AI System: The collaboration between Globant and PharmaMar has launched a multi-agent AI framework that achieves over 90% accuracy in complex data retrieval and reduces insight time by up to 15-fold, significantly accelerating the selection of cancer drug candidates.
- Efficient Data Processing: This system analyzes over 4,500 research documents to prioritize the 10 most viable treatment combinations out of 8,000 possibilities, a task that would have taken months for human researchers, now completed in seconds, greatly enhancing R&D efficiency.
- Innovation Culture Promotion: The partnership not only strengthens PharmaMar's ability to reuse institutional knowledge but also fosters a culture of digital innovation across teams, with plans to extend capabilities to hypothesis generation, real-time compliance checks, and automated scientific reporting content creation.
- Precision Drug Discovery: By integrating Globant's AI technologies, PharmaMar can process thousands of documents in seconds, simulate scenarios, and focus research efforts on areas with the highest potential, thereby offering greater hope for patient treatments.
See More
Globant Files 2025 Annual Report with SEC
- Annual Report Submission: Globant S.A. filed its 2025 Annual Report with the SEC on February 27, 2026, demonstrating the company's commitment to transparency and regulatory compliance.
- Financial Information Access: Shareholders can access the 2025 Annual Report via the company's or SEC's website and request free copies of the complete audited financial statements, reflecting the company's dedication to shareholder service.
- Global Business Presence: With over 28,700 employees across more than 30 countries, Globant serves prominent companies like Google, Electronic Arts, and Santander, showcasing its extensive influence in the digital technology services sector.
- Industry Recognition: The company was named a Worldwide Leader in CX Improvement by the IDC MarketScape report and featured as a business case study at Harvard, MIT, and Stanford, further solidifying its industry position.
See More
